Molecular pathways linking the gut microbiome to antitumor immunity.

Gut microbiome–derived metabolites are linked to key molecular pathways that influence antitumor immunity, affecting therapy efficacy and tumor development.

• Why it matters: Understanding how gut bacteria and their metabolites modulate immune responses is crucial for improving cancer treatments and developing new therapeutic strategies.
• What they did: The authors review current knowledge of bacterial species and metabolites that impact antitumor immune activities, including epigenetic changes, receptor signaling, and cytokine production, highlighting specific metabolites produced in the gut microbiome.
• The result: Findings suggest these metabolites can alter molecular pathways associated with antitumor immunity, emphasizing the need for further evaluation in preclinical and clinical settings to enhance therapeutic outcomes.